Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 652.99B | 614.49B | 562.56B | 491.73B | 427.55B |
Gross Profit | 258.10B | 226.19B | 197.82B | 156.17B | 130.22B |
EBITDA | 180.14B | 145.40B | 127.26B | 104.22B | 81.49B |
Net Income | 92.63B | 82.65B | 66.29B | 60.20B | 38.37B |
Balance Sheet | |||||
Total Assets | 990.97B | 975.72B | 903.10B | 823.18B | 771.29B |
Cash, Cash Equivalents and Short-Term Investments | 233.46B | 207.92B | 219.79B | 188.34B | 165.79B |
Total Debt | 156.68B | 178.11B | 186.42B | 154.74B | 187.54B |
Total Liabilities | 316.24B | 337.42B | 339.36B | 305.19B | 319.67B |
Stockholders Equity | 674.57B | 637.68B | 563.67B | 514.32B | 448.83B |
Cash Flow | |||||
Free Cash Flow | 98.14B | 82.72B | 44.98B | 44.07B | 33.82B |
Operating Cash Flow | 132.92B | 118.18B | 69.31B | 71.91B | 63.40B |
Investing Cash Flow | -34.25B | -92.16B | -37.38B | 10.23B | -42.52B |
Financing Cash Flow | -71.00B | -57.45B | -1.77B | -53.83B | 28.17B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $6.70B | 11.06 | 13.91% | 3.46% | 0.78% | 7.49% | |
79 Outperform | $14.85B | 11.30 | 15.52% | ― | -2.47% | -43.12% | |
76 Outperform | $7.69B | 28.13 | 5.38% | 1.26% | -8.23% | -52.61% | |
75 Outperform | $8.66B | 12.26 | 29.99% | 2.50% | -0.98% | 21.64% | |
74 Outperform | $5.56B | 12.19 | 10.00% | 2.96% | -3.15% | -6.70% | |
66 Neutral | $5.16B | 13.45 | 15.90% | 2.09% | -1.66% | -9.20% | |
57 Neutral | HK$25.53B | 4.08 | -2.03% | 6.11% | -0.31% | -67.64% |